A Randomized, Double-blind, Placebo-controlled, Parallel-group, Phase 2 Study to Evaluate the Safety and Efficacy of CT1812 in Subjects with Mild to Moderate Alzheimer's Disease.

Project: Research

StatusActive
Effective start/end date10/01/1931/12/20